tiprankstipranks
Trending News
More News >

Lynne Parshall Insider Profile

4 Followers
Lynne Parshall, Director at Ionis Pharmaceuticals, holds 91.34K shares in Ionis Pharmaceuticals (Ticker: IONS), holds ― shares in Akcea Therapeutics (Ticker: AKCA), holds ― shares in Foghorn Therapeutics (Ticker: FHTX).
tipranks
Lynne Parshall

Lynne Parshall
Ionis Pharmaceuticals (IONS)
Director

Ranked #4,662 out of 102,596 Corporate Insiders

Profitable Transactions

100%
10 out of 10 Profitable Transactions

Average Return

+31.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
78.62%
21.38%
0.00%
A breakdown of Lynne Parshall's holdings

Insider Roles

Ionis Pharmaceuticals
(IONS)
Director
Cytokinetics
(CYTK)
Director
Foghorn Therapeutics
(FHTX)
Director
Roles that Lynne Parshall holds in companies

Most Profitable Insider Trade

Stock:
Cytokinetics
(CYTK)
Rating:Informative Sell
Date:Jul 01, 2024 - Jul 01, 2025
Return:+38.50%
The most profitable trade made by Lynne Parshall

Lynne Parshall's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Ionis Pharmaceuticals
Jul 17, 2025
Director
Uninformative Buy
171.32K
$3.80M
AKCA
Akcea Therapeutics
Foghorn Therapeutics
Director
Cytokinetics
May 15, 2025
Director
Uninformative Buy
$1.03M
RGLS
Regulus
Oct 11, 2012
Uninformative Buy
$57.52M
List of latest transactions for each holding click on a transaction to see Lynne Parshall's performance on stock

Lynne Parshall insider profile FAQ

What is the percentage of profitable transactions made by Lynne Parshall?
The percentage of profitable transactions made by Lynne Parshall is 100%.
    What is the average return per transaction made by Lynne Parshall?
    The average return per transaction made by Lynne Parshall is 31.70%.
      What stocks does Lynne Parshall hold?
      Lynne Parshall holds: IONS, AKCA, FHTX, CYTK, RGLS stocks.
        What was Lynne Parshall’s latest transaction?
        Lynne Parshall latest transaction was an Uninformative Buy of $171.32K.
          What was Lynne Parshall's most profitable transaction?
          Lynne Parshall’s most profitable transaction was an Informative Sell of CYTK stock on July 1, 2024. The return on the trade was 38.50%.
            What is Lynne Parshall's role in Ionis Pharmaceuticals?
            Lynne Parshall's role in Ionis Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.